Sanara MedTech Inc.SMTINASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +35.24% | +48.70% | +26.42% | +28.14% | +21.51% |
| Gross Profit Growth | +37.87% | +51.28% | +29.75% | +31.64% | +24.29% |
| EBITDA Growth | -367.15% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +2.22% | -0.04% | +1.79% | +1.70% | +1.52% |
| Weighted Average Shares Diluted Growth | +2.22% | -0.04% | +1.79% | +1.70% | +4.97% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +92.69% | +0.00% | +0.00% | +0.00% | +6.14% |
| Free Cash Flow Growth | +128.39% | +0.00% | +0.00% | +0.00% | -45.28% |
| Receivables Growth | +62.65% | +58.81% | +29.14% | +13.12% | -0.88% |
| Inventory Growth | -40.09% | -41.64% | -25.30% | -1.48% | +12.55% |
| Asset Growth | +17.32% | +19.25% | +35.91% | +34.59% | -19.72% |
| Book Value per Share Growth | -12.18% | -12.07% | -16.78% | -16.54% | -84.80% |
| Debt Growth | +169.19% | +173.78% | +282.22% | +179.22% | +48.46% |
| R&D Expense Growth | +37.82% | +270.19% | +17.74% | +27.58% | -24.27% |
| SG&A Expenses Growth | -100.00% | +0.00% | +32.41% | +0.00% | +0.00% |